Dr. David B. Masters, Ph.D. – Chairman

Dr. Masters is the Chief Technology Officer and President of Gel-Del and is the inventor of Gel-Del's technology. Dr. Masters is internationally recognized as an expert in biomaterials and local drug delivery. Over the past 16 years he has developed several medical products, including implantable medical devices for drug delivery, neurologic, vascular and dermal applications.

Dr. Masters received his B.A. in Biochemistry and Biopsychology from Rutgers University at New Brunswick, N.J., with Scholar Distinction in 1989, a Master's Degree in Chemistry, and a Ph.D. in 1992 in Behavioral and Neural Sciences at Rutgers University, including two awards for excellence in research. After Rutgers, he went to Harvard Medical School as a Research Fellow at the Department of Anesthesiology to study solid implantable dosage forms in collaboration with Dr. Robert Langer of M.I.T. This led to patented work on biodegradable polymers for local delivery of analgesic agents, a startup company, and many published reports. Dr. Masters became an Instructor in Anesthesiology at Harvard before leaving for The Mayo Clinic in 1993, where he was an Assistant Professor and Associate Consultant.

Dr. Masters has over 60 peer-reviewed publications, book chapters and abstracts, and over 18 patents issued or pending. In 2000, Dr. Masters left The Mayo Clinic and founded Gel-Del Technologies, Inc., which began operation in 2000.

Mr. John F. Dolan

Attorney – Intellectual Property Group
Fredrickson & Byron, P.A.

John F. Dolan is a Shareholder in Fredrikson & Byron's Intellectual Property service area. He concentrates his practice in the areas of intellectual property asset management, chemical, biotech and mechanical patent prosecution, trademark prosecution, trade secret protection, intellectual property litigation, and intellectual property agreements.

In the course of his legal career, John has been a litigation attorney in public and private practice and has served as a patent examiner with the U.S. Patent and Trademark Office. In this role as a patent examiner he examined patent applications related to organic chemistry and biotechnology. This opportunity, coupled with his legal experience, has given him a unique perspective of legal issues relevant to technology based companies.